Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DSNKY |
---|---|---|
09:32 ET | 978 | 33.59 |
09:38 ET | 565 | 34.55 |
09:39 ET | 800 | 34.6 |
09:43 ET | 728 | 34.51 |
09:50 ET | 1060 | 34.6 |
10:17 ET | 568 | 34.5487 |
10:19 ET | 172 | 34.55 |
10:21 ET | 100 | 34.51 |
10:32 ET | 140 | 34.54 |
10:39 ET | 728 | 34.59 |
10:48 ET | 208 | 34.495 |
10:50 ET | 114 | 34.473 |
10:53 ET | 2165 | 34.4 |
11:11 ET | 208 | 34.495 |
11:15 ET | 423 | 34.46 |
11:22 ET | 1495 | 34.55 |
11:40 ET | 409 | 34.59 |
11:42 ET | 2760 | 34.505 |
11:44 ET | 900 | 34.47 |
11:49 ET | 179 | 34.505 |
12:02 ET | 354 | 34.42 |
12:03 ET | 1300 | 34.46 |
12:05 ET | 445 | 34.505 |
12:09 ET | 750 | 34.46 |
12:25 ET | 665 | 34.505 |
12:27 ET | 1208 | 34.573 |
12:36 ET | 1381 | 34.488 |
12:43 ET | 245 | 34.42 |
12:54 ET | 131 | 34.505 |
12:56 ET | 203 | 34.505 |
01:19 ET | 990 | 34.51 |
01:32 ET | 393 | 34.59 |
01:35 ET | 1333 | 34.4795 |
02:02 ET | 107 | 34.51 |
02:04 ET | 111 | 34.494 |
02:08 ET | 2143 | 34.59 |
02:09 ET | 585 | 34.47 |
02:15 ET | 419 | 34.59 |
02:27 ET | 300 | 34.51 |
02:33 ET | 434 | 34.59 |
02:36 ET | 528 | 34.43 |
02:56 ET | 158 | 34.4795 |
03:05 ET | 485 | 34.515 |
03:12 ET | 190 | 34.5055 |
03:14 ET | 120 | 34.46 |
03:21 ET | 112 | 34.525 |
03:32 ET | 156 | 34.542 |
03:36 ET | 728 | 34.53 |
03:41 ET | 797 | 34.59 |
03:45 ET | 475 | 34.59 |
03:59 ET | 360 | 34.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Daiichi Sankyo Co Ltd | 67.4B | 51.3x | --- |
Theravance Biopharma Inc | 455.5M | -9.7x | --- |
Sanara Medtech Inc | 270.9M | -60.2x | --- |
Nektar Therapeutics | 323.2M | -1.9x | --- |
Aquestive Therapeutics Inc | 281.3M | -7.2x | --- |
Esperion Therapeutics Inc | 414.9M | -2.2x | --- |
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $67.4B |
---|---|
Revenue (TTM) | $10.3B |
Shares Outstanding | 1.9B |
Dividend Yield | 0.71% |
Annual Dividend Rate | 0.2444 USD |
Ex-Dividend Date | 09-27-23 |
Pay Date | 12-15-23 |
Beta | 0.32 |
EPS | $0.67 |
Book Value | $5.65 |
P/E Ratio | 51.3x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | 40.3x |
Operating Margin | 13.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.